mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |